abstract |
Use of an antibody that specifically binds to an epitope within residues 1-10 of AĆ¢ (beta amyloid) where the isotype of the antibody is human IgG1 in the manufacture of a medicament for preventing or treating a disease associated with amyloid deposits in the brain. Also covered are polynucleotides encoding said antibody and pharmaceutical compositions comprising said antibody or polynucleotide. |